Soleno Therapeutics Inc

NASDAQ:SLNO  
1.92
-0.02 (-1.29%)
Earnings Announcements

Soleno Therapeutics Reports Q3 Loss Per Share of $0.11

Published: 11/10/2020 21:12 GMT
Soleno Therapeutics Inc (SLNO) - Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.11.
Q3 Earnings per Share Estimate $-0.09 -- Refinitiv Ibes Data (analyst estimates).
As of September 30, 2020, Soleno Had Cash and Cash Equivalents of Approximately $56.1 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.